Live Terminal
Telegram

Max Healthcare, Fortis, Apollo, Aster: Hospital stocks steal show on D-Street with up to 14% rally - Buy now or wait?

Share on WhatsApp Telegram
⚡ Instant Key Takeaways (TL;DR)
🎯
Core Development: Max Healthcare, Fortis, Apollo, Aster: Hospital stocks steal show on D-Street with up to 14% rally - Buy now or wait?
📊
Market & Financial Impact: Hospital stocks rallied up to 14% over five trading sessions amid optimism about corporate earnings and growth prospects. Apollo Hospitals, Fortis, Max Healthcare and Aster DM Quality Care all advanced on Friday, with brokerages maintaining Buy ratings on Apollo, Fortis and Max.
💡
Actionable Insight: 🟢 Bullish Trigger: Positive business expansion or earnings beat may attract institutional and retail buying.

Shares of hospital stocks like Max Healthcare, Fortis Hospital, Aster DM Quality Care and Apollo Hospitals Enterprise rallied as much as 14% over the past five trading sessions. The sharp rally in the segment has come amid optimism around corporate earnings and strong growth visibility.

Shares of Apollo Hospitals, Fortis Healthcare, Max, and Aster DM closed with 5%, 2%, 3.98%, and 5.44% respectively.

Apollo Hospitals stock closed 5.09% higher at ₹9190.05 per share on BSE with an Mcap of ₹1,32,138.82 crore on Friday. The hospital stock has delivered 8.82% return in two weeks, 19.30% return in one month, and around 29% return in 2026 so far. Motilal Oswal maintained a ‘Buy’ rating for Apollo Hospitals with a target price of ₹10,400 per share.

Shares of Fortis closed 2% higher at ₹825 per share with an Mcap of ₹62,284.05 crore on Friday. Its share price value has surged 7.84% in one week, 12.12% in one month. But the stock value has declined 8.18% in 2026 so far. MOFSL gave a ‘Buy’ rating for the stock with a target price of ₹940 per share.

The company scrip closed 5.44% higher at ₹779.65 per share on BSE with a market capitalisation of ₹67,959.94 crore on Friday. The stock has delivered 7.95% return in one week, 16.85% return in one month, and 28.63% return in 2026 so far. MOFSL maintained a ‘Buy’ rating with a target price of ₹870.

📰
Official Publisher Attribution: This report is aggregated from LiveMint. ZeroLive provides live aggregation, automated sentiment synthesis, and exchange disclosure monitoring for retail market participants.
Read Original Full Coverage on LiveMint ↗
⚡
Get Breaking Stock Alerts & Q-Results on Telegram
Real-time 1200x675 image cards and financial filings delivered instantly.
Join @Zerolive_news ↗
Link copied to clipboard! ✅